KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Prepaid Assets (2016 - 2025)

Pacific Biosciences Of California has reported Prepaid Assets over the past 16 years, most recently at $10.8 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $10.8 million for Q4 2025, down 42.53% from a year ago — trailing twelve months through Dec 2025 was $10.8 million (down 42.53% YoY), and the annual figure for FY2025 was $10.8 million, down 42.53%.
  • Prepaid Assets for Q4 2025 was $10.8 million at Pacific Biosciences Of California, down from $11.5 million in the prior quarter.
  • Over the last five years, Prepaid Assets for PACB hit a ceiling of $18.8 million in Q4 2024 and a floor of $5.6 million in Q1 2021.
  • Median Prepaid Assets over the past 5 years was $13.0 million (2022), compared with a mean of $12.6 million.
  • Biggest five-year swings in Prepaid Assets: surged 128.58% in 2021 and later plummeted 42.53% in 2025.
  • Pacific Biosciences Of California's Prepaid Assets stood at $7.4 million in 2021, then soared by 39.15% to $10.3 million in 2022, then skyrocketed by 65.61% to $17.0 million in 2023, then grew by 10.22% to $18.8 million in 2024, then plummeted by 42.53% to $10.8 million in 2025.
  • The last three reported values for Prepaid Assets were $10.8 million (Q4 2025), $11.5 million (Q3 2025), and $12.3 million (Q2 2025) per Business Quant data.